Industry Wire 195

July 24, 2024 Jake Fishman 0 min read
  1. Intermountain Chief Digital Officer steps down after 5 years.
  2. CrowdStrike implements new checks to avoid another global outage.
  3. Whistleblower alleges poor sterilization procedures at St. Luke’s Hospital.
  4. Five CFO moves from just this week.
  5. Top medtech partnerships in the first half of 2024.
  6. Medical supply giant Medline eyes $50B IPO.
  7. UCI Health, MemorialCare, LLU Health form SoCal research consortium.
  8. Tenet reports $259M net income and raises guidance.
  9. 39 healthcare providers sue United over Change cyberattack.
  10. ONC’s Micky Tripathi on creating a connected healthcare system.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology Business July 23, 2026

The Cost of Cardiology is Driven by Insurers July 23, 2026

New price transparency data reveals how wildly insurance payments, reimbursements, and facility fees for cardiology swing across insurers and states, which underscores the complexity of U.S. healthcare costs.

Cardiology Pharmaceuticals July 20, 2026

An Oral PCSK9i and What it Means for Merck July 20, 2026

PCSK9 inhibitors are some of the most effective LDL-lowering drugs out there, but they’ve all required injection, and some even refrigeration. That just changed, however, with the FDA’s approval of Merck's Lipfendra (enlicitide), the first ever oral PCSK9i.

Heart Failure July 22, 2026

How Earlier Hemodynamic Insight May Help Guide Heart Failure Management July 22, 2026

Heart failure continues to place a significant burden on patients and the healthcare system, with nearly 7 million Americans living with heart failure, with prevalence expected to reach nearly 9 million by 2030. Despite advances in guideline-directed medical therapy (GDMT), many patients still face high risks of hospitalization, mortality, and reduced quality of life.